It has been previously shown that, in patients with primary operable colorectal cancer, approximately one-third of patients had an elevated circulating concentration of C-reactive protein preoperatively and that these patients had a significantly poorer outcome (McMillan et al, 2003). The gene discussed is CRP; the disease is colorectal cancer.